• Explore /
  • Poster
  • / Randomized phase II trial of gemcitabine, avelumab and carboplatin versus no neoadjuvant therapy preceding surgery for cisplatin-ineligible muscle-invasive urothelial carcinoma (MIUC): SWOG GAP trial (S2011).

Randomized phase II trial of gemcitabine, avelumab and carboplatin versus no neoadjuvant therapy preceding surgery for cisplatin-ineligible muscle-invasive urothelial carcinoma (MIUC): SWOG GAP trial (S2011).

Abstract Video & Slides Poster

Authors

Guru P. Sonpavde

Guru P. Sonpavde

Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA

Guru P. Sonpavde , Melissa Plets , Michael A. Liss , Joshua J Meeks , Daniel P. Petrylak , Suzanne Cole , Rana R. McKay , Shilpa Gupta , Sandi Hita , Taj Pereira , Rick Bangs , Catherine Tangen , Ian Murchie Thompson Jr., Seth P. Lerner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04871529

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr TPS591)

DOI

10.1200/JCO.2022.40.6_suppl.TPS591

Abstract #

TPS591

Poster Bd #

M8

Abstract Disclosures

Similar Posters

First Author: Hailiang Zhang

First Author: Chiara Mercinelli

First Author: Raj Satkunasivam

First Author: Nieves Martinez Chanza